An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Severe Hypertriglyceridemia

Interventions

DRUG

Epanova

DRUG

Lovaza

Trial Locations (4)

Research Site, Kansas City

Research Site, Cincinnati

Research Site, Philadelphia

Research Site, Chocoutimi